{"count": 6, "results": [{"_id": "35633523", "pmid": 35633523, "pmcid": "PMC9258994", "title": "Focal adhesion kinase-related pathways may be suppressed by metformin in vascular smooth muscle cells in high glucose conditions", "journal": "Endocrinol Diabetes Metab", "authors": ["Soleimani AA", "Ghasmpour G", "Mohammadi A", "Gholizadeh M", "Abkenar BR", "Najafi M"], "date": "2022-07-01T00:00:00Z", "doi": "10.1002/edm2.351", "meta_date_publication": "2022 Jul", "meta_volume": "5", "meta_issue": "4", "meta_pages": "e351", "score": 50247.504, "text_hl": "The results showed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may suppress the proliferation and migration of VSMCs via @GENE_PTK2 @GENE_5747 @@@FAK@@@-related pathways and may retard the progression of @<m>DISEASE_Constriction_Pathologic</m> @DISEASE_MESH:D003251 @@@vessel stenosis@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@.", "citations": {"NLM": "Soleimani AA, Ghasmpour G, Mohammadi A, Gholizadeh M, Abkenar BR, Najafi M. Focal adhesion kinase-related pathways may be suppressed by metformin in vascular smooth muscle cells in high glucose conditions Endocrinol Diabetes Metab. 2022 Jul;5(4):e351. PMID: 35633523", "BibTeX": "@article{35633523, title={Focal adhesion kinase-related pathways may be suppressed by metformin in vascular smooth muscle cells in high glucose conditions}, author={Soleimani AA and Ghasmpour G and Mohammadi A and Gholizadeh M and Abkenar BR and Najafi M}, journal={Endocrinol Diabetes Metab}, volume={5}, number={4}, pages={e351}}"}}, {"_id": "40236865", "pmid": 40236865, "title": "Coronary imaging characteristics and risk factors in patients with type 2 diabetes mellitus with coronary heart disease complication.", "journal": "World J Diabetes", "authors": ["Pan CJ", "Wang T", "Yin RH", "Tang XQ", "Hu CH"], "date": "2025-04-15T00:00:00Z", "doi": "10.4239/wjd.v16.i4.99151", "meta_date_publication": "2025 Apr 15", "meta_volume": "16", "meta_issue": "4", "meta_pages": "99151", "score": 50242.965, "text_hl": "The observation group demonstrated a higher right coronary artery (RCA@<m>DISEASE_Constriction_Pathologic</m> @DISEASE_MESH:D003251 @@@) stenosis@@@ index (t = 6.730, P = 0.000), circumflex coronary artery (LCX) @<m>DISEASE_Constriction_Pathologic</m> @DISEASE_MESH:D003251 @@@stenosis@@@ index (t = 5.738, P = 0.000), and total @<m>DISEASE_Constriction_Pathologic</m> @DISEASE_MESH:D003251 @@@stenosis@@@ index (t = 7.049, P = 0.000) than the control group. ", "citations": {"NLM": "Pan CJ, Wang T, Yin RH, Tang XQ, Hu CH. Coronary imaging characteristics and risk factors in patients with type 2 diabetes mellitus with coronary heart disease complication. World J Diabetes. 2025 Apr 15;16(4):99151. PMID: 40236865", "BibTeX": "@article{40236865, title={Coronary imaging characteristics and risk factors in patients with type 2 diabetes mellitus with coronary heart disease complication.}, author={Pan CJ and Wang T and Yin RH and Tang XQ and Hu CH}, journal={World J Diabetes}, volume={16}, number={4}, pages={99151}}"}}, {"_id": "35998511", "pmid": 35998511, "title": "Effects of metformin on changes of miR-19a and miR-221 expression associated with myocardial infarction in patients with type 2 diabetes.", "journal": "Diabetes Metab Syndr", "authors": ["Mansouri F", "Seyed Mohammadzad MH"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.dsx.2022.102602", "meta_date_publication": "2022 Sep", "meta_volume": "16", "meta_issue": "9", "meta_pages": "102602", "score": 50239.125, "text_hl": "AIM: This study aimed to measure the expression of two microRNAs, which are involved in the risk of MI and @<m>DISEASE_Constriction_Pathologic</m> @DISEASE_MESH:D003251 @@@vascular stenosis@@@ among @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users and non-users with MI. ", "citations": {"NLM": "Mansouri F, Seyed Mohammadzad MH. Effects of metformin on changes of miR-19a and miR-221 expression associated with myocardial infarction in patients with type 2 diabetes. Diabetes Metab Syndr. 2022 Sep;16(9):102602. PMID: 35998511", "BibTeX": "@article{35998511, title={Effects of metformin on changes of miR-19a and miR-221 expression associated with myocardial infarction in patients with type 2 diabetes.}, author={Mansouri F and Seyed Mohammadzad MH}, journal={Diabetes Metab Syndr}, volume={16}, number={9}, pages={102602}}"}}, {"_id": "23561047", "pmid": 23561047, "pmcid": "PMC3642024", "title": "The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats", "journal": "Cardiovasc Diabetol", "authors": ["Lu J", "Ji J", "Meng H", "Wang D", "Jiang B", "Liu L", "Randell E", "Adeli K", "Meng QH"], "date": "2013-04-05T00:00:00Z", "doi": "10.1186/1475-2840-12-58", "meta_date_publication": "2013 Apr 5", "meta_volume": "12", "meta_issue": "", "meta_pages": "58", "score": 50040.844, "text_hl": "This study investigated the protective effects and underlying mechanisms of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in balloon-injury induced @<m>DISEASE_Constriction_Pathologic</m> @DISEASE_MESH:D003251 @@@stenosis@@@ in @GENE_INS @GENE_3630 @@@insulin@@@ resistant @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Lu J, Ji J, Meng H, Wang D, Jiang B, Liu L, Randell E, Adeli K, Meng QH. The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats Cardiovasc Diabetol. 2013 Apr 5;12():58. PMID: 23561047", "BibTeX": "@article{23561047, title={The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats}, author={Lu J and Ji J and Meng H and Wang D and Jiang B and Liu L and Randell E and Adeli K and Meng QH}, journal={Cardiovasc Diabetol}, volume={12}, pages={58}}"}}, {"_id": "31369842", "pmid": 31369842, "title": "Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats.", "journal": "Free Radic Biol Med", "authors": ["Zhang WX", "Tai GJ", "Li XX", "Xu M"], "date": "2019-11-01T00:00:00Z", "doi": "10.1016/j.freeradbiomed.2019.07.030", "meta_date_publication": "2019 Nov 1", "meta_volume": "143", "meta_issue": "", "meta_pages": "153-163", "score": 50037.277, "text_hl": "This study provided new therapeutic strategies for @<m>DISEASE_Constriction_Pathologic</m> @DISEASE_MESH:D003251 @@@vascular stenosis@@@ associated with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@.", "citations": {"NLM": "Zhang WX, Tai GJ, Li XX, Xu M. Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats. Free Radic Biol Med. 2019 Nov 1;143():153-163. PMID: 31369842", "BibTeX": "@article{31369842, title={Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats.}, author={Zhang WX and Tai GJ and Li XX and Xu M}, journal={Free Radic Biol Med}, volume={143}, pages={153-163}}"}}, {"_id": "26642102", "pmid": 26642102, "title": "AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.", "journal": "Endocr Pract", "authors": ["Goodman NF", "Cobin RH", "Futterweit W", "Glueck JS", "Legro RS", "Carmina E", "American Association of Clinical Endocrinologists (AACE)", "American College of Endocrinology (ACE)", "Androgen Excess and PCOS Society"], "date": "2015-12-01T00:00:00Z", "doi": "10.4158/EP15748.DSCPT2", "meta_date_publication": "2015 Dec", "meta_volume": "21", "meta_issue": "12", "meta_pages": "1415-26", "score": 50014.938, "text_hl": "In @SPECIES_9606 @@@women@@@ under 60 years of age undergoing coronary angiography, the presence of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovaries@@@ on sonography has been associated with more arterial segments with >50% @<m>DISEASE_Constriction_Pathologic</m> @DISEASE_MESH:D003251 @@@stenosis@@@, but the relationship between @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ and actual cardiovascular events remains unclear. ", "citations": {"NLM": "Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Endocr Pract. 2015 Dec;21(12):1415-26. PMID: 26642102", "BibTeX": "@article{26642102, title={AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.}, author={Goodman NF and Cobin RH and Futterweit W and Glueck JS and Legro RS and Carmina E and American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) and Androgen Excess and PCOS Society}, journal={Endocr Pract}, volume={21}, number={12}, pages={1415-26}}"}}]}